Cyclophosphamide (generic), Cytoxan

Cyclophosphamide (generic), Cytoxan Newswire (Page 3)

Comprehensive Real-Time News Feed for Cyclophosphamide (generic), Cytoxan. (Page 3)

Results 41 - 60 of 453 in Cyclophosphamide (generic), Cytoxan

  1. Study identifies genetic variants linked with severe skin reactions to antiepileptic drugRead the original story

    Aug 5, 2014 | PhysOrg Weblog

    Researchers have identified genetic variants that are associated with severe adverse skin reactions to the antiepileptic drug phenytoin, according to a study in the August 6 issue of JAMA .

    Comment?

  2. ChemoCentryx, Inc. Announces Financial Results For The Second Quarter Ended June 30, 2014Read the original story

    Aug 5, 2014 | BioSpace

    ChemoCentryx, Inc., , a clinical-stage biopharmaceutical company focused on autoimmune diseases, inflammatory disorders and cancer, announced today its financial results for the second quarter ended June 30, 2014.

    Comment?

  3. Cytotoxicity of some Russian ethnomedicinal plants and plant compounds.Read the original story

    Aug 3, 2014 | CiteULike

    To insert individual citation into a bibliography in a word-processor, select your preferred citation style below and drag-and-drop it into the document.

    Comment?

  4. OBI Pharma Announces Completion of Patient Enrollment in Phase...Read the original story

    Aug 1, 2014 | PRWeb

    OBI Pharma, Inc., a Taiwan biotech company , announced that it has completed patient enrollment in its Phase 2/3 clinical trial evaluating the safety and efficacy of its lead compound, OBI-822, an active immunotherapy for the treatment of metastatic breast cancer.

    Comment?

  5. Type of lymphoma treatment impacts degree of harm to spermRead the original story w/Photo

    Jul 28, 2014 | PhysOrg Weblog

    Lymphoma treatment has damaging effects on spermatogenesis but, in most patients, sperm production recovers within two years post-treatment, according to a study published online July 17 in Fertility and Sterility .

    Comment?

  6. Type of Lymphoma Treatment Impacts Degree of Harm to SpermRead the original story w/Photo

    Jul 28, 2014 | Mental Help Net

    Lymphoma treatment has damaging effects on spermatogenesis but, in most patients, sperm production recovers within two years post-treatment, according to a study published online July 17 in Fertility and Sterility .

    Comment?

  7. Study Results from German Cancer Research Center Provide New Insights ...Read the original story

    Jul 23, 2014 | Hispanic Business

    Editor at Clinical Oncology Week -- Current study results on Biotechnology have been published.

    Comment?

  8. National Pharmaceutical Pricing Authority moves to bring cancer drugs under price controlRead the original story w/Photo

    Jul 21, 2014 | DNA India

    Sets July 24 deadline for six pharma firms to submit pricing data of their cancer drugs, pulls them up for dithering to furnish pricing data The National Pharmaceutical Pricing Authority is moving fast on reducing prices of cancer drugs.

    Comment?

  9. Evaluation of toxicities from combined metronomic and...Read the original story

    Jul 19, 2014 | CiteULike

    To insert individual citation into a bibliography in a word-processor, select your preferred citation style below and drag-and-drop it into the document.

    Comment?

  10. Why the Market is Wrong About Baxter StockRead the original story

    Jul 18, 2014 | The Motley Fool

    Analysts continue to fret that ) will grab considerable market share in hemophilia and that generic competition for other products will add to the revenue erosion.

    Comment?

  11. UPDATE 2-Gambro acquisition boosts Baxter's salesRead the original story

    Jul 17, 2014 | Reuters

    Medical device and drug maker Baxter International Inc reported higher-than-expected quarterly adjusted earnings, driven primarily by a surge in sales of the dialysis products it gained from its acquisition of Gambro AB last year.

    Comment?

  12. Nuvilex and Austrianova Announce Results of Clinical Trial in Dogs...Read the original story

    Jul 17, 2014 | Hispanic Business

    These results were published in the . Sixteen female dogs were enrolled in the clinical trial.

    Comment?

  13. Comparison of molecular and immunocytochemical methods for detection...Read the original story

    Jul 14, 2014 | BioMed Central

    Disseminated tumor cells have potential to predict the effect of adjuvant treatment.

    Comment?

  14. Immunosuppressive treatments in multiple sclerosis.Read the original story

    Jul 11, 2014 | CiteULike

    Multiple sclerosis is a heterogeneous autoimmune disorder of the central nervous system that is enigmatic, relapsing, and in some instances progressive.

    Comment?

  15. Helsinn Announces That Phase 2/3 Pivotal Trials For NEPA...Read the original story

    Jul 10, 2014 | BioSpace

    Helsinn Announces That Phase 2/3 Pivotal Trials For NEPA , Will Be Published In The Annals Of Oncology Lugano, Switzerland, July 10th, 2014: Helsinn Group, the company focused on building quality cancer care, today announces that the complete results of the three Phase 2/3 pivotal trials for the investigational oral fixed-dose combination capsule ... (more)

    Comment?

  16. Helsinn Announces That Phase 2/3 Pivotal Trials For NEPA...Read the original story

    Jul 10, 2014 | BioSpace

    LUGANO, Switzerland, July 10, 2014 /PRNewswire/ -- Helsinn Group, the company focused on building quality cancer care, today announces that the complete results of the three Phase 2/3 pivotal trials for the investigational oral fixed-dose combination capsule of netupitant 300 mg + oral palonosetron 0.50 mg , which is licensed to Eisai Inc. in the ... (more)

    Comment?

  17. Helsinn Announces That Phase 2/3 Pivotal Trials for NEPA (netupitant...Read the original story

    Jul 10, 2014 | Applied Clinical Trials

    Helsinn Announces That Phase 2/3 Pivotal Trials for NEPA , Will be Published in the Annals of Oncology Helsinn Announces That Phase 2/3 Pivotal Trials for NEPA , Will be Published in the Annals of Oncology Helsinn Group, the company focused on building quality cancer care, today announces that the complete results of the three Phase 2/3 pivotal ... (more)

    Comment?

  18. A vaccine may cause pancreatic cancer to respond to immunotherapyRead the original story

    Jul 10, 2014 | PhysOrg Weblog

    Pancreatic ductal adenocarcinomas do not typically respond to immunotherapy, which limits treatment options for this cancer.

    Comment?

  19. Recent Findings from University of Helsinki Provide New Insights into ...Read the original story

    Jul 9, 2014 | Hispanic Business

    Editor at Cancer Gene Therapy Week -- Research findings on Biotechnology are discussed in a new report.

    Comment?

  20. Natural Killer Cell Lymphomas Market Analysis, Size, Share, Trends and Forecast 2019Read the original story

    Jul 8, 2014 | SBWire

    Lymphoma is a common blood cancer type which develops when lymphocytes multiply in an uncontrolled manner.

    Comment?